However, Liu et al. found that DCLK1 was positively related to favorable clinic-pathologic features and might be a good prognostic factor in breast cancer, especially in invasive breast cancers with neuroendocrine differentiation [28]. This evidence concerns the gene DCLK1 and breast cancer.